NEUROONE MEDICAL TECHN

NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System

23 Jun 2025 05:30:00 By Nasdaq GlobeNewswire

NeuroOne Strengthens Leadership Team with Appointment of Emily Johns as General Counsel and Corporate Secretary

03 Jun 2025 05:30:00 By Nasdaq GlobeNewswire

NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025

29 May 2025 10:05:36 By Nasdaq GlobeNewswire

NeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%

13 May 2025 04:30:00 By Nasdaq GlobeNewswire

NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor

12 May 2025 05:30:00 By Nasdaq GlobeNewswire

NeuroOne® to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time

01 May 2025 06:55:00 By Nasdaq GlobeNewswire

NeuroOne® Completes FDA Submission for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

23 Apr 2025 06:00:00 By Nasdaq GlobeNewswire

NeuroOne® Issues Letter to Shareholders

16 Apr 2025 06:00:00 By Nasdaq GlobeNewswire

NeuroOne® OneRF® Technology Success Story Featured on Fox News

14 Apr 2025 06:00:00 By Nasdaq GlobeNewswire

NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock

04 Apr 2025 05:30:00 By Nasdaq GlobeNewswire

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock

03 Apr 2025 13:05:00 By Nasdaq GlobeNewswire

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace - Update

18 Mar 2025 10:12:00 By Nasdaq GlobeNewswire

NeuroOne® CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace

18 Mar 2025 06:00:01 By Nasdaq GlobeNewswire

NeuroOne® Accelerates Timeline of 510(k) Submission to FDA for the OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain

11 Mar 2025 06:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

05 Mar 2025 06:00:00 By Nasdaq GlobeNewswire

NeuroOne® Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update

12 Feb 2025 05:00:00 By Nasdaq GlobeNewswire

NeuroOne® to Report First Quarter Fiscal Year 2025 Financial Results on Wednesday, February 12 at 8:30 a.m. Eastern Time

05 Feb 2025 08:00:00 By Nasdaq GlobeNewswire

NeuroOne® Regains Compliance with Nasdaq Listing Requirements

04 Feb 2025 07:56:00 By Nasdaq GlobeNewswire

NeuroOne® Announces Preliminary Unaudited First Quarter Fiscal 2025 Revenue Increase to a Record $6.2 Million

10 Jan 2025 05:30:00 By Nasdaq GlobeNewswire

NeuroOne® Announces Change of Virtual Investor Webinar to Friday, January 10, 2024

06 Jan 2025 05:30:00 By Nasdaq GlobeNewswire